Skip to main content

Year: 2025

Gran Tierra Announces Confirmation with Respect to Post-Offer Intention Statements Regarding i3 Energy plc

THE FOLLOWING ANNOUNCEMENT IS BEING MADE PURSUANT TO THE REQUIREMENTS OF RULE 19.6(C) OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE “CODE”), WHICH, INTER ALIA, REQUIRES A PARTY TO AN OFFER TO MAKE AN ANNOUNCEMENT AT THE END OF A PERIOD OF 12 MONTHS FROM THE DATE ON WHICH THE OFFER PERIOD ENDED CONFIRMING WHETHER IT HAS TAKEN, OR NOT TAKEN, THE COURSE OF ACTION SET OUT IN ITS STATED INTENTIONS FOR IMMEDIATE RELEASE CALGARY, Alberta, Oct. 31, 2025 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“Gran Tierra”) Rule 19.6(c) confirmation with respect to post-offer intention statements regarding i3 Energy plc (“i3 Energy”) Gran Tierra announces that, further to completion on 31 October 2024 of the recommended cash and shares acquisition of the entire issued and to be issued share capital of i3 Energy...

Continue reading

TWC Enterprises Limited Announces Third Quarter 2025 Results and Eligible Dividend

KING CITY, Ontario, Oct. 31, 2025 (GLOBE NEWSWIRE) — Consolidated Financial Highlights (unaudited)(in thousands of dollars except per shareamounts) Three months ended Nine months endedSeptember 30,2025 September 30,2024 September 30,2025 September 30,2024Net earnings 16,929 42,719 39,492 45,177Basic and diluted earnings per share 0.70 1.75 1.62 1.85Operating Data  Three months ended Nine months ended  September 30,2025 September 30,2024 September 30,2025 September 30,2024Canadian Full Privilege Golf Members     15,397 15,414Championship rounds – Canada 626,000 567,000 1,031,000 966,00018-hole equivalent championship golf courses – Canada     37.0 35.518-hole equivalent managed championship golf courses – Canada     3.5 3.5Championship rounds – U.S. 34,000 30,000 164,000 166,00018-hole equivalent...

Continue reading

FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628, for the Phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers (DFU) patients  Preparing to submit Investigational New Drug applications for the treatment of psoriasis with CYPS317 and the treatment of multiple sclerosis with CYMS101 HOUSTON, Oct. 31, 2025 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced third quarter 2025 financial results and provided a corporate update. Recent HighlightsAnnounced positive IND-enabling updates from the psoriasis research...

Continue reading

1847 Holdings Provides Update Regarding Development in Pending Civil Lawsuit

NEW YORK, NY, Oct. 31, 2025 (GLOBE NEWSWIRE) — 1847 Holdings LLC (“1847” or the “Company”) (OTCID: LBRA), a holding company specializing in identifying overlooked, deep-value investment opportunities in middle market businesses, today announced a significant favorable development in a pending civil lawsuit, Case No. #1:25-cv-08606-LAK, filed in the United States District Court for the Southern District of New York by Plaintiff Matthew Miller. On October 28, 2025, the Court entered an Order [D.E. 35], sua sponte, dismissing Plaintiff’s First Amended Complaint [D.E. 34], without prejudice to Plaintiff filing an amended complaint, no more than 40 pages long, on or before November 24, 2025. The First Amended Complaint, which had been filed four days before the Court’s issuance of its dismissal Order, alleged...

Continue reading

Middlesex Water Company Reports Third Quarter 2025 Earnings

Diluted earnings per share (“EPS”) of $0.77 Invested $72 million in water and wastewater utility infrastructure during the nine months ended September 30, 2025, or approximately 77% of the 2025 capital budget Declared $0.36 common stock cash dividend, a 5.88% increase Executed the asset purchase agreement to acquire Pinewood Acres water utility assets in DelawareISELIN, N.J., Oct. 31, 2025 (GLOBE NEWSWIRE) — Middlesex Water Company (“Middlesex” or the “Company”) (NASDAQ: MSEX) today announced financial results for the third quarter ended September 30, 2025. “We continue to focus on our selective and sustainable growth pillar, and we are pleased to announce the execution of an asset purchase agreement to acquire the water utility asset of Pinewoods Acres in Delaware,” said Nadine Leslie, Chair, President and Chief Executive...

Continue reading

Teva to Present at UBS Global Healthcare Conference and Jefferies London Healthcare Conference in November

TEL AVIV, Israel, Oct. 31, 2025 (GLOBE NEWSWIRE) —  Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva’s President and CEO, will present at two upcoming investor conferences in November as follows:UBS Global Healthcare ConferenceMonday, November 10, 2025, at 8:45 A.M. Eastern Time (ET)Jefferies London Healthcare ConferenceTuesday, November 18, 2025, at 11:00 A.M. Greenwich Mean Time (6:00 A.M. ET)To access a live webcast of the presentation, visit Teva’s Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations. An archived version of the webcast will be available within 24 hours after the end of the live discussion. About Teva Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading innovative biopharmaceutical company, enabled by...

Continue reading

Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Oct. 31, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on October 15, 2025, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 113,478 shares of Vor Bio’s common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 24,319 shares of Vor Bio’s common stock to 20 newly hired employees. The foregoing stock options and RSUs were granted as material inducements to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”).         The stock options have a ten-year term, and the exercise price is $30.22 per share, which is...

Continue reading

Unitil Completes Purchase of Maine Natural Gas Company

HAMPTON, N.H., Oct. 31, 2025 (GLOBE NEWSWIRE) — Unitil Corporation (NYSE:UTL) (unitil.com) today announced that it completed the purchase of Maine Natural Gas Company (“Maine Natural”) from Avangrid Enterprises, Inc. The Stock Purchase Agreement (the “Agreement”) between Avangrid Enterprises, Inc. and Unitil was first announced on April 1, 2025. All conditions of the Agreement, including the receipt of approvals from the Maine Public Utilities Commission, were materially completed as of the closing date. Maine Natural commenced operations in 1999 and serves approximately 6,300 residential and commercial natural gas customers in nine communities in the Greater Portland region of Maine, as well as the capital city of Augusta. Maine Natural’s gas system includes approximately 230 miles of distribution mains, providing opportunities...

Continue reading

Global Engine Group Holding Limited Receives Nasdaq Minimum Bid Price Deficiency Notice

Hong Kong, Oct. 31, 2025 (GLOBE NEWSWIRE) — Global Engine Group Holding Limited (the “Company”), a Hong Kong-headquartered integrated solutions provider in information communication technologies (“ICT”), today announced that it has received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”), dated October 27, 2025, stating that the Company is not in compliance with the requirement to maintain a minimum bid price of $1 per share as set forth under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based upon the closing bid price of the Company’s Class A ordinary shares (the...

Continue reading

NN, Inc. Executive Management to Present at the Gabelli Funds 49th Annual Automotive Symposium

CHARLOTTE, N.C., Oct. 31, 2025 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, announced today that Harold Bevis, President and Chief Executive Officer will be presenting at the Gabelli Funds 49th Annual Automotive Symposium on November 3, 2025 in Las Vegas. The presentation will begin at 4:30 p.m. PT (7:30 p.m. ET) on Monday, November 3, 2024. Investors interested in accessing the Company’s presentation may register to access the live event here. All registrants will receive a link to the event upon registration. A link to the presentation and associated materials can also be accessed through the investor section of the Company’s website at www.nninc.com. About NN, Inc.NN, Inc., a global diversified industrial company,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.